platoseedplatoseed
Simplifying complex illness care at scale
Current Description: RTHM provides virtual-first care for complex illness including Long COVID, ME/CFS, POTS, and mast cell activation. Many clinics focus on teaching patients how to better cope with symptoms, which is helpful, but we don’t stop there. We develop collaborations & partnerships so our patients access to the most promising testing and root-cause directed early therapies for their illness(es) with the goal of simplifying and streamlining the most efficient and effective clinical pathways so they can be scaled in the form of low cost online modules overseen remotely by clinicians. In conjunction with clinical care, RTHM operates a clinical lab and collects deep molecular data with robust clinical context to develop AI-powered diagnostics and better ways of predicting which treatments may work best for whom.
RTHM provides expert virtual care for complex, multi-system illnesses such as Long COVID, ME/CFS, POTS, and MCAS. It combines an AI-driven health platform with access to clinician-led guidance, personalized roadmaps, and optional cash-pay services for meds and labs.
The product centers on an intelligence platform that unifies a user’s health data into a single comprehensive health picture, analyzes data to surface patterns and clinical insights, and generates a personalized health roadmap. Users can view diagnoses, symptoms, and lab data, receive treatment and lab recommendations, and take actions such as requesting labs, accessing medications, or scheduling expert consultations. The platform operates alongside cash-pay clinician services, with prescriptions reviewed by licensed clinicians and optional access to a clinic for deeper care.
Who it’s for: Individuals with complex, multi-system illnesses (Long COVID, ME/CFS, POTS, MCAS, hEDS) seeking structured, data-driven guidance and access to clinician-led care.
mentions of widespread adoption (thousands joining), availability of a clinic, and ongoing hiring/clinical team context
Dr. Kellogg’s struggle with a mystery illness led him to pioneer technology for measuring thousands of molecules in self-collected blood microsamples. This allows for a better understanding of health fluctuations and the impacts of health interventions in detail. When combined with wearable sensors and symptom tracking, this technology allows for real-time health monitoring and pattern discovery with unprecedented resolution. PhD in Microfluidics and Systems Biology from ETH Zurich.
Physician treating post-viral illnesses & ME/CFS for >5 yrs, Long COVID for the past year. Member of the ME/CFS Clinician Coalition & co-author of the latest Coalition ME/CFS expert management guidance published in Mayo Clinic Proceedings 8/25/2021. Streamlined/mapped the complex decision making, testing & treatment logic for Long COVID & frequently diagnosed co-morbid illnesses (incl ME/CFS) so it can be more rapidly utilized by new healthcare providers and scaled.
Formerly “Inc” · why startups rename →
Addressing Loneliness and Isolation for Seniors
Automating repetitive processes in healthcare
